Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/1/2026

1. NKE
2. TSLA
3. NVDA
4. BE
5. STZ
6. ABVX
7. KKR
8. GOOGL
9. TALO
10. SPY

Go back to Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs
(NASDAQ: ENSC) Delayed: 0.29 --0 (-0%)
Previous Close $0.29    52 Week High $ 
Open $0.29    52 Week Low $ 
Day High $0.29    P/E N/A 
Day Low $0.29    EPS $ 
Volume 14,212